Forecasting News and Research

RSS

Emerging Pandemic Threats program to combat newly emerging diseases of animal origin

The United States Agency for International Development (USAID) is launching an Emerging Pandemic Threats (EPT) program that builds on the successes of the Agency's long-standing programs in disease surveillance, training, and outbreak response, particularly those addressing avian and pandemic influenza.

22 Oct 2009

Insurers vs. Dems: Battle over AHIP report leads to 'grudge match'

An industry-sponsored report forecasting soaring health insurance prices as a result of reform plans ignited a fight between insurers and Democrats, and doused a fragile truce between top insurance lobbyist Karen Ignagni and White House health adviser Nancy-Ann DeParle, TIME reports. After a years-long relationship and more-than-weekly phone calls despite tensions over reform plans, the recent episode "shattered the thin trust between the Administration and the insurance lobby."

19 Oct 2009

IMS Health introduces IMS MIDAS Global Biologics

IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS MIDAS Global Biologics™, a powerful offering that enables the company’s clients to make more confident decisions as they assess opportunities in the fast-growing, $120 billion worldwide biologics market.

15 Oct 2009

Connexin Software announces updated EMR software version to support H1N1 vaccine administration

With initial shipments of the much anticipated H1N1 vaccine arriving in doctors’ offices last week, Connexin Software today announced it is delivering an expedited update of its Office Practicum pediatric EMR with features to support the special forecasting, administration, and billing requirements of the new vaccine.

14 Oct 2009

Global pharmaceutical market to grow by 4 - 6 percent: IMS Health

IMS Health reported today that the value of the global pharmaceutical market in 2010 is expected to grow 4 - 6 percent on a constant-dollar basis, exceeding $825 billion, driven by stronger near-term growth in the U.S. market.

8 Oct 2009

TGen's annual economic impact can grow to $321 million by 2025

The Translational Genomics Research Institute (TGen) provides Arizona with an annual total economic impact of $77.4 million, according to the results of an independent analysis released today.

30 Sep 2009

Research study on the U.S. life expectancy

The Great Depression had a silver lining: During that hard time, U.S. life expectancy actually increased by 6.2 years, according to a University of Michigan study published in the current issue of the Proceedings of the National Academy of Sciences.

29 Sep 2009

New version of Adis R&D Insight global pipeline database launched

Wolters Kluwer Pharma Solutions, Inc., a leading provider of market data and competitive intelligence to the pharmaceutical and biotech industries, today introduced a powerful, new version of its popular Adis R&D Insight global pipeline database.

24 Sep 2009

EU-U.S. trans-disciplinary research agenda for synthetic biology

The Wilson Center's Synthetic Biology project recently received two grants from the National Science Foundation. One will support a Transatlantic Exploratory Workshop on the Implications of Cutting-Edge Biotechnologies for Sustainability Science and Policy, and the other will support research on the use of on-line prediction markets to explore emerging issues in synthetic biology.

23 Sep 2009

HRI offers in-house data resources on subscription basis

Health Research International, a leading medical products consulting firm, is pleased to announce the availability of several of its proprietary in-house data resources on a subscription basis.

23 Sep 2009

Biochemists are developing a new system to better understand antibiotic resistance

Rice University biochemists are developing a system of "evolutionary forecasting" to better understand the mechanisms of antibiotic resistance.

22 Sep 2009

Pharmacyclics announces financial results for fourth quarter and FY 2009

Pharmacyclics, Inc. today reported financial results for its fourth quarter and fiscal year ended June 30, 2009. During the fourth quarter of fiscal 2009 Pharmacyclics incurred a GAAP net loss of $5.4 million, or $0.20 per share, compared to a net loss of $4.6 million, or $0.18 per share for the fourth quarter of fiscal 2008.

18 Sep 2009

BioClinica obtains Tourtellotte Solutions

BioClinica, Inc., a global provider of clinical trial services, today announced that it has acquired privately-held Tourtellotte Solutions, Inc. (Tourtellotte), a leader in software and services for the bio-pharmaceutical industry.

From Clario 16 Sep 2009

2nd West Coast Forum: An opportunity to gather the latest information on clinical supply chain management

The Center for Business Intelligence (CBI) is pleased to announce the full agenda for their 2nd West Coast Forum on Clinical Supply Chain Management. The conference takes place in Burlingame, CA, on October 28-29, 2009.

11 Sep 2009

IBM study reveals the need for smart drug manufacturer supply chain systems

Reducing the risk of counterfeit drugs and contaminated medications amidst the complexity of global manufacturing are among the top concerns of the pharmaceutical and life sciences industries today, according to a new IBM (NYSE: IBM) study. More than 50 percent of executives polled say their companies fail to respond quickly enough to pandemics and other emergencies because of lapses in their supply chain.

10 Sep 2009

JDA Software helps pharmaceutical companies enhance supply-chain management

Successful supply chain management, including managing demand, planning API and formulation production, packaging and distributing, is a goal shared by all pharmaceutical manufacturers. According to PharmaTech.com, effective supply-chain management is particularly important as the pharmaceutical industry seeks ways to reduce costs, maintain regulatory compliance, and adhere to quality and safety standards.

3 Sep 2009

National Health Partners issues guidance for third-quarter 2009

National Health Partners, Inc. (OTCBB: NHPR), a leading provider of unique discount healthcare membership programs, announced that it expects to generate positive cash flows from operating activities of almost $100,000 during August, representing the first time in the company’s history that it has achieved positive cash flows from operating activities for a full month.

21 Aug 2009

Evidence of Malaria origins, could lead to vaccine development

"Malaria may have jumped to humans from chimpanzees much as AIDS did, U.S. researchers reported on Monday in a [Proceedings of the National Academy of Sciences] study they hope could help in developing a vaccine against the infection," Reuters reports.

4 Aug 2009

Scientists discover original source of malignant malaria

Researchers have identified what they believe is the original source of malignant malaria: a parasite found in chimpanzees in equatorial Africa.

3 Aug 2009

Flu mortality formula is potentially misleading, say scientists

A standard calculation used in forecasting potential numbers of deaths during the swine flu pandemic risks misleading healthcare planners by being open to both over- and under-estimation of the true figures, say the authors of new research published today in the British Medical Journal.

15 Jul 2009